BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
0.77
0.03 (4.05%)
At close: Aug 18, 2025, 10:42 AM
BriaCell Therapeutics Income Statement
Financials in USD. Fiscal
year is
August - July.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 5.18K | 5.16K | 5.18K | 5.09K | 5.17K | 5.15K | 5.08K | n/a | 4.84K | 4.84K | 4.8K | n/a | 4.69K | 4.69K | 4.69K |
Gross Profit | n/a | n/a | n/a | -67.06K | -5.18K | -5.16K | -5.18K | -5.09K | -5.17K | -5.15K | -5.08K | n/a | -4.84K | -4.84K | -4.8K | n/a | -4.69K | -4.69K | -4.69K |
Operating Income | -6.33M | -7.17M | -5.15M | -5.77M | -9.23M | -9.83M | -8.5M | -7.71M | -5.68M | -4.49M | -5.4M | -4.23M | -4.12M | -3.65M | -2.28M | -1.59M | -4.81M | -190.15K | -380.37K |
Interest Income | 26.63K | 46.83K | 13.05K | n/a | 15.61K | 81.59K | 190.81K | 208.78K | 253.49K | 240.59K | 188.35K | 82.36K | 35.99K | 12.08K | 6.3K | 60.55K | 39.00 | n/a | n/a |
Pretax Income | -6.22M | -6.34M | -5.83M | -1.25M | 1.69M | -11.33M | 5.96M | -2.42M | -4.89M | -15.81K | -1.11M | -576 | -10.02M | 11.16M | -27.53M | 1.04M | 2.95M | -301.78 | -561.3 |
Net Income | -6.13M | -6.29M | -5.8M | -1.21M | 1.72M | -11.29M | 6M | -2.42M | -4.89M | -11.88M | -1.11M | -576 | -10.02M | 11.16M | -27.53M | -2.72M | 2.95M | -301.78 | 233.91K |
Selling & General & Admin | 1.52M | 1.49M | 1.49M | 1.36M | 1.57M | 1.57M | 1.65M | 2.54M | 1.82M | 1.43M | 2.15M | 1.37M | 1.85M | 1.94M | 1.41M | -1.03M | -2.39M | 20.74K | -230.4K |
Research & Development | 4.81M | 5.68M | 3.67M | 4.41M | 7.66M | 8.26M | 6.86M | 5.17M | 3.86M | 3.05M | 3.25M | 2.87M | 2.91K | 1.71M | 875.64K | 724.84 | 1.38K | 93.43K | 116.84K |
Other Expenses | n/a | -1K | 1K | 1K | -150.75 | -145 | -122 | -571 | -66.97 | -63.86 | -65.39 | 1.67M | -44.19 | 431.00 | 3.82K | 21.77 | -4.86 | 3.67K | 3.52K |
Operating Expenses | 6.33M | 7.17M | 5.15M | 5.77M | 9.23M | 9.83M | 8.5M | 7.71M | 5.68M | 4.49M | 5.4M | 5.91M | -2.3M | 3.65M | 2.28M | 1.59M | 4.81M | -180.06K | -233.91K |
Interest Expense | 36.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 979.00 | n/a | 62.46K | 45.79K | 15.72K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.33M | 7.17M | 5.15M | 5.77M | 9.23M | 9.83M | 8.5M | 7.71M | 5.68M | 4.49M | 5.4M | 6.7K | -2.3M | 3.65M | 2.28M | 1.59M | 4.81M | 243.21 | 506.74 |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.03M | -4.3M | 11.58M | -35.99K | 12.08K | -106.73K | -1.21M | 7.82M | -44K | -14.5K |
Shares Outstanding (Basic) | 3.74M | 2.7K | 1.76K | 1.13K | 1.06K | 1.06K | 805.00 | 1.04K | 1.02K | 1.03K | 1.03K | 908.00 | 1.02K | 19.44K | 1.01K | 795.00 | 316.00 | 51.00 | 51.00 |
Shares Outstanding (Diluted) | 3.74M | 2.7K | 1.78K | 1.19K | 1.06K | 1.06K | 1.11K | 1.06K | 1.03K | 1.03K | 1.03K | 1.03K | 1.02K | 1.23K | 1.01K | 795.72 | 316.27 | 51.46 | 51.63 |
EPS (Basic) | -1.64 | -3.39 | -4.55 | -1.41 | 2.22 | -14.25 | 7.81 | -3 | -6.41 | -15.28 | -1.46 | -0.56 | -12.57 | 13.48 | -33.55 | -25.26 | 11.46 | -5.86 | -10.87 |
EPS (Diluted) | -1.64 | -3.39 | -4.59 | -1.48 | 2.22 | -14.25 | -10.33 | -3.05 | -6.5 | -15.37 | -1.46 | -0.63 | -12.57 | 0.73 | -33.55 | -25.26 | 11.46 | -5.86 | -10.87 |
EBITDA | -6.16M | -7.14M | -5.13M | -5.7M | -9.23M | -9.83M | -8.5M | -2.42M | -5.67M | -4.48M | -5.4M | -15.74M | -6.13M | 11.16M | -27.53M | -2.8M | 3.02M | -186.33K | -401.79K |
EBIT | -6.19M | -7.17M | -5.15M | -5.77M | -9.23M | -9.83M | -8.5M | -2.42M | -5.68M | -4.49M | -5.4M | -15.75M | -6.13M | 11.16M | -27.53M | -2.8M | 3.01M | -190.15K | -405.6K |
Depreciation & Amortization | 26.66K | 26.66K | 26.66K | 72.44K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 4.8K | 3.81K | 4.69K | 3.81K | 3.81K |